Illumina Gets FDA Clearance for BeadXpress | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina today announced that the US Food and Drug Administration has granted 510(k) clearance for the firm's BeadXpress multiplex system.

The FDA cleared the system, which includes the BeadXpress Reader and VeraScan software, for in vitro diagnostic applications. Illumina said that it can simultaneously detect multiple analytes in a DNA sample using the firm's VeraCode holographic microbead technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."